Stocks / SOLV
SOLV stock forecast
SOLVENTUM CORP · Healthcare · Health Information Services
The model's rating
Outperform
SOLV is rated Outperform as of September 29, 2026: its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth.
Create a free account to compare any two stocks; the numeric score is part of Premium.
SOLV is not among the 20 largest holdings published for 2026 Q4. See the portfolio
SOLV against the S&P 500
| Period | SOLV | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.2% | -0.3% |
| 3 months | +12.5% | +2.5% |
| Year to date | +11.2% | +12.7% |
| 1 year | +20.8% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $88.15 |
| Market cap | 15.01 Billion |
| P/E (trailing 12 months) | 10.7 |
| P/S (trailing 12 months) | 1.8 |
| P/B (latest quarter) | 3.1 |
| Gross margin | 54.7% |
| Net profit margin | 17.3% |
| Return on equity | 29.0% |
| Beta | 0.6 |
As of August 5, 2026.
SOLV and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 14.08 Billion | Greatly Underperform | SOLV vs CRL |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 16.94 Billion | Underperform | ZBH vs SOLV |
| RVTY | REVVITY INC | 17.06 Billion | Underperform | RVTY vs SOLV |
| BAX | BAXTER INTERNATIONAL INC | 12.41 Billion | Greatly Outperform | |
| TECH | BIO-TECHNE CORP | 11.36 Billion | Greatly Underperform | |
| DVA | DAVITA INC | 11.16 Billion | Greatly Outperform |
Questions
What does the Upfront Investment model say about SOLV?
The model rates SOLVENTUM CORP (SOLV) "Outperform" as of September 29, 2026, which means its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the SOLV rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is SOLV in the Upfront Investment model portfolio?
SOLV is not among the 20 largest holdings published for 2026 Q4.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.